39
© 2016 Universitair Ziekenhuis Gent 1 Glaucoma and vascular risk factors What is the evidence? Ghent University Hospital Belgium Prof. dr. Ph. Kestelyn Dr. AM. Stevens Dr. A. Hoste On behalf of the Belgian Glaucoma society

Glaucoma and vascular risk factors What is the evidence?

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Glaucoma and vascular risk factors What is the evidence?

© 2016 Universitair Ziekenhuis Gent 1

Glaucoma and vascular risk factors

What is the evidence?

Ghent University Hospital

Belgium

Prof. dr. Ph. Kestelyn

Dr. AM. Stevens

Dr. A. Hoste

On behalf of the Belgian Glaucoma society

Page 2: Glaucoma and vascular risk factors What is the evidence?

2 2 © 2008 Universitair Ziekenhuis Gent

Glaucoma or the glaucomas?

common denominator : optic neuropathy

death of retinal ganglion cells

loss of axonal nerve fibers

typical functional and structural defects

functional defects = visual field changes

structural defects = optic disc damage

Page 3: Glaucoma and vascular risk factors What is the evidence?

3 3 © 2008 Universitair Ziekenhuis Gent

The family tree of glaucomatous disease

Primary glaucomas

primary open-angle glaucoma or POAG

(IOP elevated or nl)

primary angle-closure glaucoma

(IOP elevated)

Secondary glaucomas (IOP elevated)

2-ary to other eye diseases (e.g. diabetic

retinopathy)

2-ary to trauma

2-ary to inflammation

iatrogenic (corticosteroids)

Congenital glaucoma (IOP elevated)

Page 4: Glaucoma and vascular risk factors What is the evidence?

4 4 © 2008 Universitair Ziekenhuis Gent

Page 5: Glaucoma and vascular risk factors What is the evidence?

5 5 © 2008 Universitair Ziekenhuis Gent

The family tree of glaucomatous disease

Primary glaucomas

primary open-angle glaucoma or POAG

(IOP elevated or nl)

primary angle-closure glaucoma

(IOP elevated)

Secondary glaucomas (IOP elevated)

2-ary to other eye diseases (e.g. diabetic

retinopathy)

2-ary to trauma

2-ary to inflammation

iatrogenic (corticosteroids)

Congenital glaucoma (IOP elevated)

Page 6: Glaucoma and vascular risk factors What is the evidence?

6 6 © 2008 Universitair Ziekenhuis Gent

Definition of primary open-angle

glaucoma (POAG)

a chronic, progressive optic neuropathy

characteristic morphological changes at the optic nerve

head and retinal nerve fiber layer

absence of other ocular disease

absence of congenital anomalies

open angle

optic disc changes observed as glaucomatous cupping

retinal nerve fiber layer changes detected as VF defects

Page 7: Glaucoma and vascular risk factors What is the evidence?

7 7 © 2008 Universitair Ziekenhuis Gent

Epidemiology of primary open-angle

glaucoma (POAG)

second leading cause of blindness in Europe and

worldwide

most frequent cause of irreversible blindness

unusual under age of 50 yrs

2% in patients over 60 yrs

4% in patients over 80 yrs

genetic influence (first-degree relative risk X 10)

racial factors (African > European > Asian people)

Page 8: Glaucoma and vascular risk factors What is the evidence?

8 8 © 2008 Universitair Ziekenhuis Gent

Page 9: Glaucoma and vascular risk factors What is the evidence?

9 9 © 2008 Universitair Ziekenhuis Gent

Page 10: Glaucoma and vascular risk factors What is the evidence?

10 10 © 2008 Universitair Ziekenhuis Gent

Page 11: Glaucoma and vascular risk factors What is the evidence?

11 11 © 2008 Universitair Ziekenhuis Gent

Pathogenesis of primary open-angle

glaucoma (POAG)

alterations of the connective tissues at the optic disc are

coincident with loss of axons

axons grouped together at the disc undergo apoptosis

together, pointing to the disc as the 1-ary site of injury

interruption of axonal transport leads to death

initial ganglion cell death leads to a toxic environment

with 2-ary retinal ganglion cell loss

role of IOP? (pressure theory)

role of ischaemia? (vascular theory )

Page 12: Glaucoma and vascular risk factors What is the evidence?

12 12 © 2008 Universitair Ziekenhuis Gent

Diagnosis of primary open-angle

glaucoma (POAG)

detection of structural and functional defects

structural defects:

cup/disc ratio (ophthalmoscopy, fundus photography)

thinning of nerve fiber layer (OCT)

C/D

ratio =

0.3

C/D

ratio =

0.9

Page 13: Glaucoma and vascular risk factors What is the evidence?

13 13 © 2008 Universitair Ziekenhuis Gent

OCT = optical coherence tomography

Page 14: Glaucoma and vascular risk factors What is the evidence?

14 14 © 2008 Universitair Ziekenhuis Gent

Diagnosis of primary open-angle

glaucoma (POAG)

detection of structural and functional defects

automated perimetry

Page 15: Glaucoma and vascular risk factors What is the evidence?

15 15 © 2008 Universitair Ziekenhuis Gent

Treatment for POAG

Medical treatment

Prostaglandins (no systemic side-effects

beta-blockers (systemic side-effects)

alpha-agonists

topical and systemic carbonic anhydrase inhibitors

Laser surgery

Surgery

filtration surgery

tubes and valves

Page 16: Glaucoma and vascular risk factors What is the evidence?

16 16 © 2008 Universitair Ziekenhuis Gent

Risk factors for POAG

age

IOP

risk of developing glaucoma increases by 10 % for each mm Hg

increase in IOP

only modifiable risk factor for POAG

race/ethnicity

family history of glaucoma

first relative X10

Page 17: Glaucoma and vascular risk factors What is the evidence?

17 17 © 2008 Universitair Ziekenhuis Gent

Risk factors for POAG

myopia

ocular perfusion pressure

miscellaneous:

diabetes, systemic BP, vascular dysregulation, obstructive

sleep apnoe, migraine, Raynaud

Page 18: Glaucoma and vascular risk factors What is the evidence?

18 18 © 2008 Universitair Ziekenhuis Gent

POAG normal pressure glaucoma

IOP within normal range (10 to 21 mm Hg)

disc damage identical to POAG with high pressure

VF defects identical to POAG with high pressure

different disease or part of continous spectrum?

Page 19: Glaucoma and vascular risk factors What is the evidence?

19 19 © 2008 Universitair Ziekenhuis Gent

POAG with normal pressure

1967: MacDougald presents 14 cases (0.7%) of low-

tension glaucoma out of 2000 glaucoma patients in

the files of the Glaucoma Clinic (Dublin)

“you may feel that this is wasting time on a very low

proportion of one’s whole range of patients, but as once we

started looking we seem to have suddenly come upon a

number of them, I feel that their frequency is probably

much higher , and more careful research will yield a

considerable increase in the number detected”

Problems of low tension glaucoma, T.J. MacDougald. Transactions of the

Ophthalmological Societies of the UK, 1967

Page 20: Glaucoma and vascular risk factors What is the evidence?

20 20 © 2008 Universitair Ziekenhuis Gent

Some hard data…

Author Year Total

glaucomas

Total with

normal IOP

Percentage

Armaly 1966 189 129 68.3

Bengtsson 1987 33 16 48.5

Hollows, Graham 1966 20 7 35

Klein et al 1992 104 33 31.7

Leibowitz et al 1980 40 21 52.5

Mason et al 1989 147 53 36.1

Shiose 1983 151 99 65.6

Smith 1985 400 120 30

Sommer et al 1991 194 114 58.8

Bonomi 2001 60 24 28.5

Page 21: Glaucoma and vascular risk factors What is the evidence?

21 21 © 2008 Universitair Ziekenhuis Gent

Effect of IOP lowering on POAG

several RCT have shown

IOP lowering reduces rate of progression in patients with POAG

IOP lowering reduces the incidence of POAG in patients with

ocular hypertension

IOP lowering also reduces rate of progression in POAG with

normal pressure

despite adequate IOP control, a number of patients are

relentlessly progressive

e.g. progression still occurred in 12 % of patients with 30% IOP

reduction in the Collaborative Normal Tension Glaucoma Study

other factors must be involved !

Page 22: Glaucoma and vascular risk factors What is the evidence?

22 22 © 2008 Universitair Ziekenhuis Gent

Some candidates...

systemic hypertension

low diastolic ocular perfusion pressure (nocturnal

dippers)

disturbances of the autoregulation of the optic nerve

head bloodflow

arteriosclerosis

vascular dysregulation

Page 23: Glaucoma and vascular risk factors What is the evidence?

23 23 © 2008 Universitair Ziekenhuis Gent

blood pressure and IOP

meta-analysis of 60 observational studies

Pooled av. Increase in IOP for 5 mm Hg increase in

diastolic PP

0.17 mm HG (95% CI = 0.11-0.23)

pooled av. increase in IOP for 10 mm Increase in syst BP

0.26 mmHg(95% CI = 0.23-0.28)

pooled RR for POAG comparing patients with

hypertension to those without :

1.16 (95% CI = 1.05-1.28)

Zhao et al. The association of blood pressure and POAG: a meta-

analysis. AJO, 2014

Page 24: Glaucoma and vascular risk factors What is the evidence?

24 24 © 2008 Universitair Ziekenhuis Gent

Ocular perfusion pressure (OPP) and

POAG

no direct measurements available

mean OPP = 2/3 mean arterial pressure – IOP

(corrrection for drop in BP between arm and eye in

upright position)

systolic OPP = systemic syst BP – IOP

diastolic OPP = systemic diastolic BP – IOP

some studies use posture-correcting formulas, others

do not...

in general BP and IOP measured only once

some studies adjust for IOP, others do not...

Page 25: Glaucoma and vascular risk factors What is the evidence?

25 25 © 2008 Universitair Ziekenhuis Gent

Costa et al. OPP in glaucoma. Acta Ophthalmol, 2014

Page 26: Glaucoma and vascular risk factors What is the evidence?

26 26 © 2008 Universitair Ziekenhuis Gent

Page 27: Glaucoma and vascular risk factors What is the evidence?

27 27 © 2008 Universitair Ziekenhuis Gent

OPP and POAG

Results from population based studies

low OPP is a risk factor for the prevalence and the

progression of glaucoma

6 of 14 studies not adjusted for IOP

adjustment for IOP means using arterial blood pressure

as a proxy measure for OPP

most measures carried out once

all measures carried out a daytime

good evidence that BP is lowest at night and IOP

highest in the early morning hours (Weinreb et al)

Page 28: Glaucoma and vascular risk factors What is the evidence?

28 28 © 2008 Universitair Ziekenhuis Gent

Circadian variation in arterial blood

pressure and POAG

a meta-analysis of 5 studies ( n = 286)

ambulatory BP measurements

separate data for daytime and highttime

definition of nocturnal pressure dip

assessment of VF over at least 2 years

Bowe et al. Circadian variation in arterial blood pressure and glaucomatous

optic neuropathy_A systematic review and meta_analysis. Am J

Hypertension, 2015

Page 29: Glaucoma and vascular risk factors What is the evidence?

29 29 © 2008 Universitair Ziekenhuis Gent

Page 30: Glaucoma and vascular risk factors What is the evidence?

30 30 © 2008 Universitair Ziekenhuis Gent

systolic nocturnal dip

diastolic nocturnal dip

Page 31: Glaucoma and vascular risk factors What is the evidence?

31 31 © 2008 Universitair Ziekenhuis Gent

Nocturnal dippers and POAG

significant association between progression of VF

defects in patients with POAG (high presssure and

normal pressure glaucoma) and nocturnal blood

pressure dips

OPP fluctuations with ischemic episodes of the optic

nerve head

important to monitor nocturnal BP especially in patients

with cardiovascular risk factors or diseases and on

antihypertensive or vaso-active medication

no conclusions about overdipping from the data

Authors recommend careful adjustment of BP lowering

drugs and repeated 24-hor ABPM

Page 32: Glaucoma and vascular risk factors What is the evidence?

32 32 © 2008 Universitair Ziekenhuis Gent

POAG and over-dippers

POAG patients (n = 314)

mean IOP < 15 mm HG and fluctuations < 5 mmHg

automated perimetry, 24-hr BP monitoring and diurnal

IOP measurements

Pillunat et al. Nocturnal blood pressure in POAG. Acta Ophthalmol,

2015.

Page 33: Glaucoma and vascular risk factors What is the evidence?

33 33 © 2008 Universitair Ziekenhuis Gent

Distribution of non-dippers, physiological dippers

and over- dippers in systemic normotensive and

hypertensive patients with POAG

Page 34: Glaucoma and vascular risk factors What is the evidence?

34 34 © 2008 Universitair Ziekenhuis Gent

Mean deviation and interquartile ranges in the 3

dipping groups

worse

Page 35: Glaucoma and vascular risk factors What is the evidence?

35 35 © 2008 Universitair Ziekenhuis Gent

Median PSD and interquartile ranges

worse

Page 36: Glaucoma and vascular risk factors What is the evidence?

36 36 © 2008 Universitair Ziekenhuis Gent

Conclusions

systemic normotensive patients with nocturnal

overdipping had more VF loss than overdippers with

systemic hypertension

There was no difference between patients with POAG

and high IOP and POAG with normal IOP

Therefore, ambulatory BP measurements should not be

restricted to POAG patients with normal pressure

Page 37: Glaucoma and vascular risk factors What is the evidence?

37 37 © 2008 Universitair Ziekenhuis Gent

POAG and PVD (primary vascular

dysregulation )

disturbance of autoregulation of ocular blood flow

often patients with low blood pressure, cold extremities,

reduced feeling of thirst, low BMI, frequent migraines,

altered drug sensitivity

over-dippers or non-dippers

unstable oxygen supply

“a sick eye in a sick body” (J Flammer)

Grieshaber et al. What is the link between vascular dysregulation and

glaucoma? Survey of Ophthalmol, 2007.

Page 38: Glaucoma and vascular risk factors What is the evidence?

38 38 © 2008 Universitair Ziekenhuis Gent

In conclusion...

Page 39: Glaucoma and vascular risk factors What is the evidence?

39 39 © 2008 Universitair Ziekenhuis Gent

The secret wish of the BGS

how reliable is a single 24-hrs BP monitoring?

is this procedure also apt to pick up cardiac rythm

disorders? (S Drance)

how is autoregulation measured or examined in other

vascular beds?

could we reach a consensus on a standard examination

protocol that catches the most important vascular risk

factors and use this as a template for the collaboration

between ophthalmologist and cardiologist in Belgium?